# FDA Inspection 1069823 - Biomat USA, Inc. - September 27, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/535f72ee-2f7c-4e19-aa58-774ac4959d34
Source feed: FDA_Inspections

> FDA Inspection 1069823 for Biomat USA, Inc. on September 27, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1069823
- Company Name: Biomat USA, Inc.
- Inspection Date: 2018-09-27
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1269041 - 2025-04-10](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/349938e4-7f75-4cbe-8951-86fe40a923e3)
- [FDA Inspection 1269041 - 2025-04-10](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/66a8ab1f-c46b-4393-b074-b3459256bc92)
- [FDA Inspection 922584 - 2015-04-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/8d3e79c9-09a0-42fd-99d4-a9982457ca5e)
- [FDA Inspection 683933 - 2010-09-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/3583ee41-a2d9-4062-8188-209fc26dd9f8)

Company: https://www.keypedia.com/companies/biomat-usa-inc/a50ff076-0057-4de1-b32c-f2875dadc0e3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d